Literature DB >> 23561816

Strategies to maintain biventricular circulation in patients with high-risk anatomy.

Sitaram M Emani1, Pedro J del Nido.   

Abstract

Although hypoplasia of left heart structures presents with a spectrum of severity, management decisions are typically dichotomous: single-ventricle palliation or biventricular repair. Since the long-term outcomes of single-ventricle palliation are sub-optimal, strategies to aggressively pursue biventricular circulation in patients with borderline left heart structures have been developed. Recent strategies and surgical techniques to rehabilitate the left heart in patients with borderline left heart are described.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561816     DOI: 10.1053/j.pcsu.2013.01.003

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  4 in total

1.  Staged Biventricular Repair-Oriented Strategy in Borderline Biventricular Repair Candidates with Ventricular Septal Defect.

Authors:  Yuki Nakamura; Ikuo Hagino; Hiromichi Nakajima; Mitsuru Aoki
Journal:  Pediatr Cardiol       Date:  2015-06-24       Impact factor: 1.655

2.  Development of an echocardiographic scoring system to predict biventricular repair in neonatal hypoplastic left heart complex.

Authors:  Christopher Robin Mart; Aaron Wesley Eckhauser
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

3.  Half-turned truncal switch operation after single ventricle palliation in a patient with borderline left heart hypoplasia.

Authors:  Tak-Hyuk Oh; Hanna Jung; Joon Yong Cho; Youngok Lee
Journal:  J Cardiothorac Surg       Date:  2020-10-09       Impact factor: 1.637

Review 4.  Hypoplastic Left Heart Syndrome: Is There a Role for Fetal Therapy?

Authors:  Andreas Tulzer; James C Huhta; Julian Hochpoechler; Kathrin Holzer; Thomas Karas; David Kielmayer; Gerald Tulzer
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.